Project Grant HT94252310867

This Project Grant award of $1,106,902.00 was provided by the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The award supports research at the University of Texas Southwestern Medical Center in Dallas, Texas to "delineate tumor-immune contexture that shapes clear cell renal cell carcinoma (ccRCC) metastatic progression and response to immunotherapy." The 3-year project aims to advance the understanding of the tumor-immune environment in ccRCC and how it impacts disease progression and response to immunotherapy treatments. The University of Texas System is the parent organization of the primary awardee, the University of Texas Southwestern Medical Center, and has similarly provided research services under prior federal grant awards.